SILO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silo Pharma Inc (SILO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The financial performance is weak, with significant declines in net income, EPS, and gross margin. Technical indicators show no strong buy signals, and there are no recent positive news or catalysts to drive the stock higher. Additionally, there is no significant trading activity from hedge funds, insiders, or Congress. Given the lack of compelling reasons to invest and the user's preference for long-term growth, it is best to hold off on buying this stock.
The MACD is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 70.146, and moving averages are converging, showing no clear trend. Key resistance levels are at 0.576 and 0.645, while support levels are at 0.353 and 0.284. The stock has a 30% chance to rise 4.12% in the next week and 4.33% in the next month, but these probabilities are not strong enough for a long-term buy decision.
NULL identified. No recent news or significant trading activity from hedge funds, insiders, or Congress.
Weak financial performance in Q4 2025, with a 49.06% drop in net income, 82.05% drop in EPS, and gross margin declining by 116.07%. Lack of significant trading trends or positive sentiment.
In Q4 2025, revenue remained flat YoY at 18026. Net income dropped significantly by 49.06% to -881530. EPS fell by 82.05% to -0.07, and gross margin declined by 116.07% to -14.77%. Overall, the financial performance shows no growth trends.
No analyst rating or price target changes available for SILO.
